We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Virtuous circle?

18 November 2003 By Robert Cyran

The German conglomerate is rumoured to be in advanced talks to sell its asthma, urology and metabolic units to GlaxoSmithKline. The rumours are not new, but a recently announced plan to cut R&D spend by 30% means several programs must go. Glaxo is a natural buyer.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)